The trajectory of patients who die from metastatic prostate cancer: a population-based study.
Anna CollinsVijaya SundararajanJeremy MillarJodie BurchellBrian LeMei KrishnasamySue-Anne McLachlanPeter HudsonLinda MileshkinJennifer PhilipPublished in: BJU international (2018)
Half of all decedents first admitted for a multiday stay with mPCa survived <4 months thereafter. They had a marked symptom burden, underwent multiple procedures and had multiple admissions. In all, 40% of patients did not receive any hospital-based palliative care. Several opportunities exist to improve the timely transition to palliative care services with mPCa. These data form a benchmark against which future improvements to palliative care integration may be measured.
Keyphrases
- palliative care
- advanced cancer
- prostate cancer
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- squamous cell carcinoma
- small cell lung cancer
- primary care
- radical prostatectomy
- prognostic factors
- peritoneal dialysis
- mental health
- big data
- patient reported
- patient reported outcomes
- artificial intelligence
- health insurance